The Complete Equity Capital Markets (ECM) Guide

Understanding The Complete Equity Capital Markets (ECM) Guide: A Complete Overview

Equity capital markets is the product group inside an investment bank that takes companies public, raises follow-on equity for already-listed issuers, and structures convertibles and other equity-linked instruments. It sits at the intersection of corporate finance, securities law, market mechanics, and investor psychology, and it is where some of the most visible work in finance happens. When a company files an S-1, runs a roadshow, prices an IPO at the night-before pricing call, and rings the bell the next morning, every step of that arc has been driven by ECM bankers operating from inside the bank's investment banking division.

Globally, ECM was a $957 billion business in 2025, up 25% year on year, with the Americas accounting for $473 billion, Asia-Pacific $309 billion, and EMEA $176 billion. The US IPO market alone raised $75 billion, the highest since 2021, with marquee deals including Medline (the largest IPO of the year at $6.27 billion), CoreWeave at $1.5 billion, Klarna at $1.37 billion, and Chime, Circle, and Figma headlining a strong recovery year. Convertible issuance topped $117 billion globally, propelled by AI-related capital expenditure and a smaller cohort of crypto-treasury issuers using converts as Bitcoin-acquisition fuel.

This guide covers everything ECM bankers actually do, from the team architecture inside an investment bank through the full IPO process, the alternatives (SPACs, direct listings, dual-track sales), the post-IPO equity products, the convertibles desk, ECM's distinct valuation and pricing discipline, the global market backdrop, and the careers and interviews that get candidates into this seat. Every article is written from the perspective of the ECM banker in the investment banking division, with the trading floor and the equity syndicate desk treated as essential context and counterparties rather than as the focus of the work.

Every full-service investment bank organizes its ECM function around the same basic problem: equity offerings combine confidential information about an issuer with active trading in that issuer's securities, which forces the bank to split the work across functions that span both sides of an information barrier. The result is a recognizable structure across bulge brackets, with smaller variations at middle market and elite boutique firms.

Origination, Syndicate, Equity-Linked, and Private Placements

Origination is the part of ECM closest to the issuer. Origination bankers work alongside the bank's coverage team to pitch ideas, propose offering structures, draft the S-1, manage the SEC review process, and run the marketing effort. They sit on the private side of the wall because they handle confidential, deal-specific information.

Syndicate sits between origination and the trading floor. Syndicate managers run the order book during a deal, set the price range, recommend the final pricing to the issuer's board, and decide allocations. They operate behind the same wall as origination but coordinate continuously with sales coverage on the trading floor (who is talking to the actual investors) to gather demand information.

Equity-linked is a specialized product team that handles convertibles, mandatory convertibles, and structured equity. Because convertibles combine equity-option mechanics with credit risk, the desk is staffed by structurers who can model option prices, discuss credit, and engage with the convertible arbitrage funds that buy most of the issuance. Private placements teams handle bespoke transactions where equity (or equity-linked instruments) gets sold to a small group of professional investors rather than through a public offering.

ECM in IBD vs. the Equity Trading Floor

A subtlety that trips up most candidates is the relationship between ECM bankers (in IBD) and the equity sales and trading floor. The IBD ECM banker owns the structuring, the documentation, the issuer relationship, and the offering economics. The equity trading floor executes the marketing to investors through equity sales coverage, runs the order book through the syndicate desk, and stabilizes the stock through ECM trading. They are different jobs reporting to different parts of the bank, separated by an information barrier, and both are essential to a successful deal.

Where ECM Teams Exist (and Where They Don't)

Not every investment bank has an ECM team. Bulge brackets like JPMorgan, Goldman Sachs, Morgan Stanley, BofA, Citi, Barclays, Deutsche Bank, and UBS all run full ECM platforms with the four sub-teams above. Middle market full-service banks like Jefferies, Stifel, Piper Sandler, Raymond James, William Blair, and Baird also have real ECM teams, often with sector specialization that makes them effective bookrunners on smaller IPOs and credible joint-bookrunners or co-managers on larger deals. Among elite boutiques, Evercore stands apart for actually maintaining a Capital Markets Advisory group that does meaningful equity-linked work, while pure-advisory firms like Centerview, PJT Partners, Perella Weinberg, and Greenhill have no ECM function by design and explicitly position themselves as conflict-free advisors who never underwrite.

Of every product an ECM desk sells, the IPO is the most visible, the most demanding, and the one that defines the bank's market reputation. A successful IPO requires twelve to eighteen months of preparation, a coordinated effort across underwriters and counsel, and tight execution at the pricing call. The process splits into three phases: pre-launch (preparation, S-1 drafting, SEC review), marketing (testing the waters, the analyst presentation, the roadshow, bookbuilding), and execution (pricing, allocation, first trade, stabilization, and lockup).

From Bake-Off to Bookbuilding

Underwriter selection happens through a "bake-off" in which the issuer invites three to six banks to pitch for the lead bookrunner mandate. Banks compete on industry expertise, distribution capability, the strength of their research analyst, and proposed valuation. The winner receives the largest share of fees and league-table credit; co-bookrunners and co-managers play smaller roles in execution but contribute distribution.

Once mandates are awarded, the working group (issuer management, counsel for both sides, auditors, and the syndicate of underwriters) holds a kickoff meeting and begins drafting the S-1 registration statement. The process takes months and involves intensive due diligence, multiple drafting sessions, and SEC review with iterative comment letters. JOBS Act emerging growth companies (issuers with less than $1.235 billion in annual gross revenue, the SEC's current inflation-adjusted threshold) can submit drafts confidentially and only file publicly fifteen days before launching the roadshow.

After the SEC declares the registration statement effective and the issuer launches the roadshow, bookbuilding from the IBD seat becomes the central work. Sales coverage on the trading floor talks to investors; syndicate (still on the private side) collects orders, indications of interest, and price-sensitivity feedback; the IBD ECM banker reads the book, recommends pricing to the issuer, and helps decide allocation.

Bookbuilding

The process by which the IPO syndicate collects orders from institutional investors during the roadshow and uses that demand information to determine the final offer price and allocation. The "book" is the running tally of orders at various price levels: an oversubscribed book at the high end of the range typically results in pricing at the high end or above; an under-subscribed book results in either lowered pricing or a delayed deal.

Pricing, Allocation, and the First Trade

The pricing call happens the night before listing. The bookrunner presents the order book, recommends a final price (or rejects the deal if demand is too thin), and the issuer's board approves. Allocation gets decided in parallel: long-only mutual funds and pension funds typically receive the largest allocations because they hold for the long term; hedge funds and momentum-driven accounts get smaller stakes; cornerstones (in Asian and European deals) receive guaranteed stakes negotiated months earlier.

On the first trading day, the syndicate desk stabilizes the stock through the greenshoe option, which lets underwriters sell up to 15% additional shares short and cover that short by either buying back stock in the open market (if the price drops) or exercising the option to acquire shares from the issuer at the IPO price (if demand is strong). After 180 days, the lockup expires and pre-IPO shareholders can sell, often producing a measurable supply shock in the stock.

Greenshoe (Over-Allotment Option)

An option that allows the IPO underwriting syndicate to sell up to 15% more shares than originally allocated, then either buy them back in the open market (if the stock drops) or exercise the option to acquire them from the issuer at the IPO price (if demand is strong). The greenshoe is the primary mechanism through which the syndicate desk stabilizes the stock in the first thirty days of trading.

The 2025 calendar produced standout examples of this process working at scale. Medline's December IPO closed the year as the single largest US listing.

When Companies Choose Alternatives

Not every company that goes public uses a traditional IPO. SPACs raise blank-check capital first and then merge with a private target through a "de-SPAC" transaction; the structure compressed dramatically after the SEC's January 2024 final rules eliminated the PSLRA safe harbor for forward-looking statements and aligned de-SPAC liability with traditional IPOs. Direct listings skip the underwriter altogether (Spotify, Slack, Coinbase, Roblox), trading existing shares without raising new capital. Dual-track processes run an IPO and an M&A sale in parallel, particularly common for PE-backed companies seeking maximum exit optionality. Each alternative trades off speed, cost, capital raise, and certainty in different ways.

Once a company is public, ECM's work doesn't end. The bulk of equity volume in any given year is actually post-IPO issuance, including follow-on offerings, block trades, ATM programs, and the entire equity-linked product set. In 2025, follow-ons and block trades together accounted for roughly the same volume as IPOs in the US market, and convertibles posted their strongest momentum since the pre-financial-crisis era, with July 2025 alone marking the busiest July since 2007.

The Follow-On Toolkit

A marketed follow-on offering looks like a miniature IPO: two to four days of investor education, a focused roadshow, and a pricing call before the next morning's open. It works for larger transactions where the issuer wants pricing tension and tight execution. An overnight bought deal compresses the same goal into a single overnight: the underwriter takes the offering onto its balance sheet at a fixed price after market close, then redistributes to investors before the open. Bought deals trade execution certainty for a wider discount and more underwriter risk.

For programmatic, opportunistic capital raising, ATM programs sell shares directly into the market through a designated sales agent at prevailing prices, "dribbling out" stock without a discount or marketing event. Block trades execute large positions overnight (often by PE sponsors selling down) using the desk's risk capital. Rights offerings give existing shareholders the option to subscribe at a discount, common in Europe and Asia. Accelerated share repurchases run buybacks through a structured forward contract with the bank.

Convertibles and the 2024-2025 Boom

The convertibles desk is its own world inside ECM. Convertible bonds are debt instruments that the holder can convert into equity at a premium to the current stock price. The issuer gets a lower coupon than straight debt because investors are paying for the embedded equity option; investors get downside protection (the bond floor) plus equity upside (the conversion option). Pricing combines bond mathematics (yield, credit spread) with option mathematics (Black-Scholes, binomial trees, the Greeks).

Convertible Bond

A debt instrument that pays a fixed coupon and matures at par, but gives the holder the right to convert the bond into a fixed number of shares of the issuing company's stock at a "conversion price" set at issuance. Issuers use convertibles to lower their cost of debt (the embedded equity option commands value, reducing the coupon needed to clear the market) at the cost of potential future dilution.

The 2024-2025 convertible boom was driven by two structural forces: AI-related capital expenditure and crypto treasury strategies. Hyperscalers and AI infrastructure companies (CoreWeave, Microsoft, Meta, others) issued record volumes of debt and convertibles to fund roughly $300 billion of annual data center and chip spend. CoreWeave alone sold a $2.25 billion convertible at a 1.75% coupon in December 2025. Separately, MicroStrategy and a small group of imitators used converts (and later perpetual preferreds) to raise capital for Bitcoin accumulation, sometimes representing 4% or more of the entire convertible bond market on issuance days.

ECM has its own valuation discipline, distinct from the M&A toolkit a coverage banker uses on a sell-side process. The work is also distinguished by an explicit demand-side dimension (who buys the stock, at what allocation, with what hold period) and by an unusually transparent fee structure (the 7% gross spread is the most famous number in investment banking).

Peer Multiples, the IPO Discount, and Underwriting Economics

For an IPO, the primary valuation anchor is peer trading multiples, not precedent transactions. Bankers identify a comparable set of public companies, calculate EV/Revenue, EV/EBITDA, or EV/Sales depending on the issuer's growth profile and profitability, and apply that range to the IPO candidate's projections. A DCF cross-check provides a sanity reference but rarely drives the recommendation, because public-market investors price on multiples and growth, not on present-value mechanics.

Once the implied fair-value range is set, the underwriter applies an IPO discount of 10-20% to the offering price. The discount creates demand cushion (the order book is more comfortably oversubscribed), reduces the risk of a broken IPO, and incentivizes investor participation by leaving upside on the table. Issuers reluctantly accept the discount because the alternative (a deal that fails to clear or breaks issue on day one) is materially worse for the company's market reputation. The "money left on the table" debate has run for decades; the consensus among practitioners is that the discount is a structural feature, not a bug.

Gross Spread (Underwriting Spread)

The fee that the underwriting syndicate earns on a public equity offering, calculated as the difference between the price at which underwriters buy shares from the issuer and the price at which they resell to the public. The standard US IPO gross spread is 7% of the offering size, allocated 20% to the management fee, 20% to the underwriting fee, and 60% to the selling concession. Larger deals (above $1 billion) often negotiate spreads of 3-5%, while smaller deals can run 7% or higher.

The gross spread decomposes into three pots: the management fee compensates the lead bookrunner for coordinating the deal, the underwriting fee compensates syndicate members for taking risk, and the selling concession compensates whoever distributes the shares. The bookrunner allocates the majority of shares and collects the largest share of the spread; in single-bookrunner deals that share is typically at least half, while in multi-bookrunner deals the lead-left captures the largest single share with remaining bookrunners splitting most of the rest, and co-managers receiving token allocations and league-table credit.

Demand, Investor Targeting, and the Order Book

Pricing is half the work; demand is the other half. ECM bankers spend significant analytical effort on shareholder analysis (who currently holds peer companies, what factors do they target, how much can they buy), investor targeting (which institutions to schedule on the roadshow), and order-book interpretation (what does a 5x oversubscribed book at the high end of the range really mean). Cornerstone and anchor investors play an outsized role in Asian and European deals, where pre-committed institutional stakes regularly cover anywhere from 30% to over 50% of an IPO before launch (a recent CATL Hong Kong listing saw cornerstones at 57%), providing demand certainty and a quality signal to other investors.

Cornerstone Investor

An institutional investor that commits in advance (typically weeks before the IPO prices) to purchase a fixed dollar amount of stock at the final IPO price, in exchange for a guaranteed allocation. Cornerstones are most prevalent in Hong Kong, Singapore, and EU IPOs, where they often cover 30-50% of the deal before public marketing begins, providing both demand certainty and a quality signal to other investors.

On allocation day, the IBD banker influences who gets stock, with explicit preference for long-only investors who hold for the long term, modest allocations to hedge funds (who often "flip" into the aftermarket), and small retail tranches where the issuer prioritizes individual investor participation. The decision rewards the investors who showed up early, scaled into the right price levels, and signaled they would hold.

ECM markets cycle. After the 2021 peak, the 2022-2023 collapse, and the 2024 partial recovery, 2025 was the year the IPO window genuinely reopened. Volumes recovered, sponsor backlogs began to clear, and a new structural force (AI-related capital expenditure) propelled both equity and convertible issuance to multi-year highs. The trajectory into 2026 looks even stronger.

A Recovery Year, Disrupted by a Government Shutdown

US IPO issuance hit $75 billion in 2025, the highest level since 2021, with 354 listings completed across the year. Healthcare led sector performance with average IPO returns of 39%, while energy lagged at -38.5% and speculative crypto and quantum names underperformed median outcomes. The marquee deals of 2025 painted a recovery story: Medline's $6.27 billion December IPO, Circle's blockbuster June debut (up 168% on the first day, +400% by year-end), CoreWeave's $1.5 billion AI infrastructure deal, Chime's $11 billion valuation fintech listing, and Klarna's $1.37 billion offering after multiple delays.

The fourth quarter brought disruption: a federal government shutdown in October-November 2025 effectively halted SEC processing and pushed an estimated 900 registration statements into a backlog. Deals that had been targeting Q4 2025 or early Q1 2026 listings shifted later, contributing to the unusually large 2026 pipeline forming by year-end. The 2026 outlook calls for $55-65 billion in US IPO proceeds against a backlog of more than 800 unicorns, with notable mega-IPOs in the pipeline including SpaceX, OpenAI, Anthropic, Kraken, and others.

Hong Kong, London, and the Global Rebalancing

The most important global ECM story of 2025 was Hong Kong reclaiming the global #1 IPO destination ranking for the first time since 2019. HKEX raised approximately $36 billion across 106 listings, driven by an "A+H" listing model that allowed mainland-Chinese A-share companies to dual-list on Hong Kong, with eight A-to-H IPOs alone raising $10.1 billion in the first half. Hong Kong's surge displaced NYSE and Nasdaq for total fundraising despite the strong US market.

In Europe, the UK's Financial Conduct Authority finalized the most significant overhaul of the Listing Rules in forty years, merging the premium and standard segments into a single regime to make London more competitive. The EU separately advanced the EU Listing Act, simplifying prospectus and disclosure rules, but the two regimes diverged for the first time post-Brexit. Cross-border listings, ADR programs, and dual-listings became a more important part of the conversation as issuers weighed which exchange to choose for primary listing.

The bookrunner league tables for 2025 reflected the recovery and the venue rebalancing. Morgan Stanley led the US IPO bookrunner table for Q1 2025 with $3.49 billion across four deals, anchored by CoreWeave's $1.5 billion debut and SailPoint's $1.38 billion offering. Goldman Sachs followed at $1.94 billion, anchored by Venture Global's $1.75 billion listing. Citigroup rounded out the top three. Across the full year, JPMorgan, Goldman Sachs, and Morgan Stanley typically rotated through the top three positions on most major league tables, with the lead-left bookrunner position carrying the largest share of the fee pot and the league-table credit that drives next year's mandates.

ECM offers a distinct lifestyle, technical skillset, and exit path inside investment banking. Candidates who choose ECM over an industry coverage group or M&A team trade some career optionality for materially better hours, a product-focused skillset, and direct exposure to the equity markets.

Recruiting, Hours, and Compensation

ECM recruiting follows the same broad timeline as all of investment banking, with bulge-bracket summer analyst applications opening in the sophomore year and full-time conversion happening through internships. Bulge brackets and middle market full-service firms hire ECM analysts directly into the group; some banks rotate analysts through ECM as part of an investment banking program before specializing. Top compensation tracks the rest of investment banking at the analyst and associate level ($100-130k base for first-year analysts and roughly $200-225k base for associates, with all-in compensation including bonus typically running 1.5-2x base, taking senior associate total comp into the $400k+ range), but ECM hours are meaningfully lighter at roughly seventy-five per week versus ninety-plus in M&A. The lifestyle differential is the single most-cited reason candidates choose ECM.

The ECM Interview

ECM interviews are noticeably less technical than M&A interviews and substantially more market-aware. Behavioral questions and "market color" questions (what's happening in the IPO market right now, what recent deals interest you, why ECM over coverage) carry more weight than DCF mechanics or accounting trivia. The technical portion of the interview tests product fluency: how an IPO is priced, what the greenshoe is, what makes a good IPO candidate, how a convertible bond differs from straight debt, how dilution gets calculated.

The single most important question is "why ECM?" Candidates who answer with generic finance interest fail; candidates who can articulate why they specifically want a product role over a coverage role, why they want exposure to public markets, and what about the day-to-day work of ECM matters to them stand out. The next most important question is "tell me about a recent IPO," where the strongest answers walk through the equity story, the pricing dynamics, the syndicate composition, and the post-IPO performance with specific numbers and dates.

This guide is built for three audiences. Candidates preparing for ECM interviews at investment banks should treat the guide as a structured curriculum, working through the IPO process, follow-ons, convertibles, valuation, and the careers and interviewing section in roughly that order. Analysts and associates working in coverage groups can use the guide as a reference when their team partners with ECM on a live deal, dipping into specific articles (the bake-off process, S-1 drafting, or syndicate fee splits) on demand. Corporate finance professionals at issuers, from CFOs preparing for an IPO to treasurers running ATM programs, can use it as a translation layer between their advisors and their boards.

Throughout the guide, every article is written from the perspective of the ECM banker in IBD, with the equity trading floor (sales, syndicate desk, ECM trading) treated as critical context and a continuous coordination partner rather than as the seat the guide is written from. The market intelligence section captures the 2025 backdrop and 2026 outlook and gets refreshed annually so the guide stays current as deal tape, regulatory rules, and global venue dynamics evolve.

The product set is broad, the technical detail goes deep where it needs to, and the global perspective is integrated rather than bolted on. By the time a reader has worked through the full guide, they should be able to walk into an ECM interview, sit in on a deal kickoff meeting, or read an S-1 with a clear understanding of who is doing what, why, and what each role contributes to the offering.